MONT SAINT-HILAIRE, QUEBEC -- (MARKET WIRE) -- September 22, 2006 -- Axcan Pharma Inc. ("Axcan" or the "Company") (TSX: AXP)(NASDAQ: AXCA) today announced that on Wednesday, September 27, 2006, President and Chief Executive Officer, Frank A.G.M. Verwiel, M.D., will present an overview of the Company at the UBS Global Life Sciences Conference to be held in New York City, NY. This presentation will take place at 3:00 p.m. (Eastern time).
